First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin

NCT00981058 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1093

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: Necitumumab
DRUG: Gemcitabine
DRUG: Cisplatin

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]